Kala-azar – A case of unknown origin fever
Keywords:
Pancytopenia, Fever, Leishmania, Visceral Leishmaniasis, Kala-azaAbstract
Leishmaniasis, a vector-borne disease, is a disease caused by
obligate intra-macrophage protozoa. It is endemic to the tropical
and subtropical regions, with a worldwide prevalence of 12 million
cases. In our country, over the last years, reports ranged from
15 to 20 cases/year. There are four main forms of Leishmaniasis
disease: cutaneous leishmaniasis, mucocutaneous leishmaniasis,
visceral leishmaniasis (kala-azar), and post-kala-azar dermal
leishmaniasis. Authors present the case of a 41 year-old woman,
immunocompetent, admitted for fever and pancytopenia, associated with anorexia, asthenia and 17 kg weight loss in seven
months. Investigation revealed to be a visceral leishmaniasis. The
treatment was started with liposomal amphotericin B, getting a
good clinical and analytic response. The disease subsided after
nine months of follow-up. This case emphasizes the importance
of considering a diagnosis of leishmaniasis, especially in non-
-endemic areas, and the need of exam reevaluation when the
diagnosis is not clear in first approach.
Downloads
References
Delacour H, Roche C, Roche B, Morand C, Koeck J-L. A travel Misadventure – Visceral Leishmaniasis in an immunocompetent Patient. JR Army Med Corps 2010; 156(3): 169-171.
Marques N, Cabral S, Sá R, Coelho F, Oliveira J, Saraiva da Cunha JG, Meliço-Silvestre A. Leishmaniose Visceral e Infecção pelo Vírus da Imunodeficiência Humana – Na era da Terapêutica Anti-retrovírica de Alta Eficácia. Acta Med Port 2007; 20:291-298.
Campino L, Maia C. Epidemiologia das Leishmanioses em Portugal. Acta Med Port 2010; 23:859-864.
Chappuis F, Sundar S, Hailu A, Chalib H, Rijal S, Peeling R, Alvar J, Boelaert M. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Mic 2007; 5:873.
World Health Organization. Urbanization: an incrising risk factor for leishmaniasis [Internet]. Weekly Epidemiological Record 2002; 44 (77): 365-372. Disponível em: http://www.who.int/wer . Acesso em: 28/06/2010.
Bern C. Clinical Manifestations and Diagnosis of Visceral Leishmaniasis. UpToDate 2010. Disponível em: http://www.uptodate.com/online. Acesso em: 20/06/2010.
Uzair M, Khan SJ, Munib S, Raheem F, Shah SH. Visceral Leishmaniasis (Kala-azar): Presentation, Diagnosis and Response to therapy (an experience of ten cases in adults). GJMC 2004; 2(1): 9-12.
Clarisa B, Palatnik-de-Sousa. Vaccines for Canine Leishmaniasis. Front Immunol 2012;3:69. doi:10.3389/fimmu.2012.00069
Bern C. Treatment of Visceral Leishmaniasis. UpToDate 2010. Disponível em: http://www.uptodate.com/online. Acesso em: 20/06/2010
Additional Files
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Medicina Interna